Evofem Takes Aim At Preventing Pregnancy And STIs With Amphora

 
• By Leah Samuel

Evofem Biosciences is preparing for Phase III trials for Amphora, an on-demand contraceptive that has surpassed Phase II endpoints in preventing bacterial sexually transmitted infections. 

Arrow flying to target with radial motion blur
Evofem is targeting multiple indications for Amphora

More from Clinical Trials

More from R&D